This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Showe, L C Articles by Croce, C M Search for Related Content PubMed PubMed Citation Articles by Showe, L C Articles by Croce, C M

 Previous Article  |  Next Article 

Mol Cell Biol. 1985 March; 5(3): 501-509

Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region.

ABSTRACT

We have cloned and sequenced the translocated c-myc gene from the Burkitt's lymphoma CA46 cell line that carries a reciprocal translocation between chromosomes 8 and 14. The breakpoint lies within the first intron of c-myc, so that the first noncoding exon of the gene remains on the 8q- chromosome. The second and third coding exons are translocated to the 14q+ chromosome into the switch region of C-alpha 1. The orientation of the c-myc gene with relationship to alpha 1 is 5' to 5', with directions of transcription in opposite orientation. DNA sequencing studies predict five changes in the amino acid sequence of the myc protein, two of which occur in a region within the second exon which is highly conserved in evolution. Southern blotting data indicate that the first exon of c-myc is rearranged 3' to 3' with the pseudo-epsilon gene. Because CA46 cells contain two rearranged mu genes, the translocation must have occurred after immunoglobulin rearrangement. The position of the breakpoint in CA46 occurs within a 20-base-pair region of the first intron of c-myc to which breakpoints have been mapped for two additional B-cell lymphomas with the t(8;14) translocation, ST486 and the Manca cell line. The region of the heavy chain locus to which c-myc has translocated is different in each case. Comparisons have been made of the levels of transcripts of the translocated c-myc gene in ST486 and CA46, where the gene is not associated with the heavy chain enhancer, with its expression in the Manca cell, in which it is. The c-myc gene is transcribed at similar levels in all three cases.

This article has been cited by other articles:

• Gregory, M. A., Hann, S. R. (2000). c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells. Mol. Cell. Biol. 20: 2423-2435 [Abstract] [Full Text]  
• Bahram, F., von der Lehr, N., Cetinkaya, C., Larsson, L.-G. (2000). c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 95: 2104-2110 [Abstract] [Full Text]  
• Basso, K., Frascella, E., Zanesco, L., Rosolen, A. (1999). Improved Long-Distance Polymerase Chain Reaction for the Detection of t(8;14)(q24;q32) in Burkitt’s Lymphomas. Am. J. Pathol. 155: 1479-1485 [Abstract] [Full Text]  
• Ronchetti, D., Finelli, P., Richelda, R., Baldini, L., Rocchi, M., Viggiano, L., Cuneo, A., Bogni, S., Fabris, S., Lombardi, L., Maiolo, A. T., Neri, A. (1999). Molecular Analysis of 11q13 Breakpoints in Multiple Myeloma. Blood 93: 1330-1337 [Abstract] [Full Text]  
• Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuki, T., Lombardi, L., Maiolo, A. T., Neri, A. (1997). A Novel Chromosomal Translocation t(4; 14)(p16.3; q32) in Multiple Myeloma Involves the Fibroblast Growth-Factor Receptor 3 Gene. Blood 90: 4062-4070 [Abstract] [Full Text]  
• Smith-Sørensen, B., Hijmans, E. M., Beijersbergen, R. L., Bernards, R. (1996). Functional Analysis of Burkitt's Lymphoma Mutant c-Myc Proteins. J. Biol. Chem. 271: 5513-5518 [Abstract] [Full Text]  
• Erikson, J, Finger, L, Sun, L, ar-Rushdi, A, Nishikura, K, Minowada, J, Finan, J, Emanuel, B., Nowell, P., Croce, C. (1986). Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science 232: 884-886 [Abstract]